Atlas Trials

A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Clinical trial NCT04994535 · COMPLETED

Trial details

NCT number
NCT04994535
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Platysma Prominence
Start date
2021-08-10
Primary completion
2023-06-14
Enrollment
426

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.